CEO SUMMARY: Ongoing reimbursement declines, coupled with other key factors, are pushing labs to seek new capabilities for their laboratory information systems (LIS). Another influence is the growth of molecular diagnostic programs in hospital labs. Molecular testing places unique demands on an LIS, which may further motivate labs to acquire newest-generation IT solutions versus upgrading […]
To access this post, you must purchase The Dark Report.